This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, F.
Right arrow Articles by Stevens, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, F.
Right arrow Articles by Stevens, R. C.

 Previous Article  |  Next Article 

Infect Immun, June 1998, p. 2420-2425, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Biophysical Characterization of the Stability of the 150-Kilodalton Botulinum Toxin, the Nontoxic Component, and the 900-Kilodalton Botulinum Toxin Complex Species

Flora Chen,1 Geoffrey M. Kuziemko,2,3 and Raymond C. Stevens2,3,*

Graduate Group in Biophysics1 and Department of Chemistry,2 University of California, and Material Sciences Division, Lawrence Berkeley National Laboratory,3 Berkeley, California 94720

Received 2 February 1998/Returned for modification 16 February 1998/Accepted 4 March 1998

Botulinum neurotoxin serotype A is initially released from the bacterium Clostridium botulinum as a stable 900-kDa complex. The serotype A 900-kDa complex is one of the forms of the toxin being used as a therapeutic agent for the treatment of various neuromuscular disorders. Previous experiments have demonstrated that the 900-kDa complex form of the toxin protects the toxin from the harsh conditions of the gastrointestinal tract. To provide molecular level details of the stability and equilibrium of the 900-kDa complex, the nontoxic component, and the toxic (botulinum neurotoxin) component, the three species have been investigated with a series of biophysical techniques at the molecular level (dynamic light scattering, proteolysis, circular dichroism, pH incubations, and agglutination assays). These experiments were conducted under harsh conditions which mimic those found along the gastrointestinal tract. Separately, exposure to denaturing and proteolytic conditions degrades both the botulinum neurotoxin and the nontoxic component. In the 900-kDa complex, the botulinum neurotoxin is protected during exposure to the gastrointestinal environment and the nontoxic component is slightly modified. Surprisingly, the toxin protects the ability of the nontoxic component to agglutinate erythrocytes. Contrary to previous reports, the purified 900-kDa complex did not have agglutination ability until after exposure to the proteolytic conditions. These experiments provide new evidence and detail for the theory that the nontoxic component and the toxic component protect one another during exposure to harsh conditions, and a molecular model is presented for the passage of the toxin through the gastrointestinal tract.

* Corresponding author. Mailing address: Department of Chemistry, University of California, Berkeley, CA 94720. Phone: (510) 643-8285. Fax: (510) 643-9290. E-mail: stevens{at}adrenaline.berkeley.edu.

Infect Immun, June 1998, p. 2420-2425, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Couesnon, A., Raffestin, S., Popoff, M. R. (2006). Expression of botulinum neurotoxins A and E, and associated non-toxin genes, during the transition phase and stability at high temperature: analysis by quantitative reverse transcription-PCR.. Microbiology 152: 759-770 [Abstract] [Full Text]  
  • Sharma, S. K., Ferreira, Joseph. L., Eblen, B. S., Whiting, R. C. (2006). Detection of Type A, B, E, and F Clostridium botulinum Neurotoxins in Foods by Using an Amplified Enzyme-Linked Immunosorbent Assay with Digoxigenin-Labeled Antibodies. Appl. Environ. Microbiol. 72: 1231-1238 [Abstract] [Full Text]  
  • Franciosa, G., Floridi, F., Maugliani, A., Aureli, P. (2004). Differentiation of the Gene Clusters Encoding Botulinum Neurotoxin Type A Complexes in Clostridium botulinum Type A, Ab, and A(B) Strains. Appl. Environ. Microbiol. 70: 7192-7199 [Abstract] [Full Text]  
  • Voth, D. E., Qa'Dan, M., Hamm, E. E., Pelfrey, J. M., Ballard, J. D. (2004). Clostridium sordellii Lethal Toxin Is Maintained in a Multimeric Protein Complex. Infect. Immun. 72: 3366-3372 [Abstract] [Full Text]  
  • Park, J.-B., Simpson, L. L. (2003). Inhalational Poisoning by Botulinum Toxin and Inhalation Vaccination with Its Heavy-Chain Component. Infect. Immun. 71: 1147-1154 [Abstract] [Full Text]  
  • Schiavo, G., Matteoli, M., Montecucco, C. (2000). Neurotoxins Affecting Neuroexocytosis. Physiol. Rev. 80: 717-766 [Abstract] [Full Text]  
  • Maksymowych, A. B., Reinhard, M., Malizio, C. J., Goodnough, M. C., Johnson, E. A., Simpson, L. L. (1999). Pure Botulinum Neurotoxin Is Absorbed from the Stomach and Small Intestine and Produces Peripheral Neuromuscular Blockade. Infect. Immun. 67: 4708-4712 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»